1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. ZYDUS LIFESCIENCES LTD.
Zydus Lifesciences Ltd.
NSE: ZYDUSLIFE | BSE: 532321
905.90 -11.00 (-1.20%)
876.9K
NSE+BSE Volume

NSE 13 Mar, 2026 3:31 PM (IST)

Watchlist

Portfolio

Alert

US FDA Approval
Zydus Lifes gets US FDA nod for its Cevimeline Hydrochloride capsules, with a market size of $27 mn See details